Trademark: ORAVANCE
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for ORAVANCE
We do not have any records of a proof of use for ORAVANCE at this moment.
Possible trademark infringements of ORAVANCE
Basic Information about ORAVANCE
- Serial Number
- 88338791
- Filing Date
- 13 Mar 2019
- Registration Number
- 7115573
- Registration Date
- 18 Jul 2023
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of ORAVANCE on the blockchain with WikiTrademarks.io.
- First use of ORAVANCE anywhere
- ORAVANCE was first used on 18 Aug 2022 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
Who owns ORAVANCE?
1. QPEX BIOPHARMA, INC. San Diego CA
2. QPEX BIOPHARMA, INC. San Diego CA
3. QPEX BIOPHARMA, INC. San Diego CA
Correspondent
- Gregory B. Phillips
- KNOBBE MARTENS OLSON & BEAR, LLP
- 2040 MAIN STREET, 14TH FLOOR
- IRVINE,CA 92614
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io